NeuroLife
ActivateNeuro Inc., launched in June 2026 from Columbus, Ohio, develops a non-invasive wearable sleeve that reads movement intent from high-density surface EMG and delivers closed-loop functional electrical stimulation to help patients regain hand and arm function after stroke or spinal cord injury, using technology licensed from Battelle.
Headquarters
Columbus, USA
Year Founded
2026
Founders
Jon Snyder (CEO)
Country
United States
Financial Information
Funding Stage
Seed
Recent Funding
$2.9M
Funding By
Battelle Memorial Institute, The NeuroTech Institute
Core Technology
High-density surface EMG decoding with closed-loop functional electrical stimulation
Product Type
Medical Device
Pipeline Stage (Very Important)
Regulatory Status
- IND Filed: N/A
- FDA/EMA Status: N/A
- Clinical Trial Registration: N/A
- Patents / IP Status: Licensed from Battelle's NeuroLife platform
Partnerships
Pharma Collaborations
None disclosed
Academic / Hospital Tie-ups
Battelle Memorial Institute (technology licence)
CRO/CDMO Partnerships
None disclosed
Market & Differentiation
Combines intent decoding and stimulation in one wearable rather than implantable neurotech